IP Library Granted Patent US 12,336,963
Granted Patent B2
US 12,336,963 · App. 18/340,034 · Granted Jun 24, 2025

Wearable intravenous fluid delivery system

Inventors: Mehdi Hatamian (Mission Viejo, CA); Mehrtash Ghalebi (Irvine, CA); Vahid Ordoubadian (Newport Beach, CA); Charbel Maksoud (Loma Linda, MO)
Assignee: Mediccene Inc.
A61J1/1468A61B5/6885A61M5/14232A61M5/168A61J1/1462A61M2205/6072A61M2205/8206
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,336,963
App. No.
18/340,034
Granted
Jun 24, 2025
Kind
B2
Abstract

An intravenous (IV) fluid delivery system include an IV bag and a fluid delivery device. The IV bag is made of many fluidic channels that keep the fluid distributed across the bag such that the bag may be easily and comfortably wrapped around the arm and shoulder of a person. At least some of the fluidic channels have a slanted shape to maximize emptying the contents of the IV bag as the fluid is injected to the patient's vein. The system includes a pump that moves the fluid into a tube and a needle that is connected to a person's vein. The processor repeatedly turns the pump on or off to gradually transfer the fluid from the IV bag into the person's vein. The processor controls the delivery of the fluid based on the patient's biometric data and/or hand movements as measured by the fluid delivery device.

Claims (36)

1. A wearable intravenous bag configured to hold a quantity of fluid, comprising:

a shoulder section comprising a first plurality of fluidic channels connected to each other through a first fluid passage, wherein the shoulder section is bendable at boundaries between adjacent fluidic channels of the first plurality fluidic channels, wherein the shoulder section is configured to be placed over a shoulder of a person and to conform to contours of the person's shoulder; and

an arm section comprising a second plurality of fluidic channels connected to each other through a second fluid passage, wherein the arm section is bendable at boundaries between adjacent fluidic channels of the second plurality of fluidic channels, wherein the arm section is configured to wrap around an arm of the person and to conform to contours of the person's arm;

wherein the first and second plurality of fluidic channels are fluidically connected to each other;

wherein at least one fluidic channel in the first and second plurality of fluidic channels has a slanted shape comprising:

a substantially flat base;

a first substantially flat side surface on a first side of the base; and

a second substantially flat side surface on a second side of the base;

wherein the first and second sides of the base are opposite to each other;

wherein an angle between the first side surface and the base is less than 75 degrees; and

wherein an angle between the second side surface and the base is less than 75 degrees.

2. The wearable intravenous bag of claim 1 , wherein the first and second substantially flat side surfaces of said at least one fluidic channel are connected to each other by a plurality of curved surfaces and at least one flat surface.

3. The wearable intravenous bag of claim 1 , wherein the first and second substantially flat side surfaces of said at least one fluidic channel are connected to each other by at least one curved surface.

4. The wearable intravenous bag of claim 1 , wherein the first and second plurality of fluidic channels are made of flexible polyvinyl chloride (PVC).

5. The wearable intravenous bag of claim 1 , wherein the first and second plurality of fluidic channels are made of a flexible polymer of plastic.

6. The wearable intravenous bag of claim 1 , wherein each fluidic channel in the first and second plurality of fluidic channels comprises one or more openings to fluidically connect the fluidic channel to other fluidic channels of the first and second plurality of fluidic channels.

7. The wearable intravenous bag of claim 1 , wherein each fluidic channel in the first and second plurality of fluidic channels has a width of between 0.1 to 0.8 inches and a length of between 1 to 9 inches.

8. The wearable intravenous bag of claim 1 , wherein the fluidic channels of at least a subset of the first plurality of fluidic channels are substantially parallel to each other.

9. The wearable intravenous bag of claim 1 , wherein at least a subset of the first plurality of fluidic channels remains substantially parallel to each other after the intravenous bag is bent around the adjacent fluidic channels of the first plurality of fluidic channels.

10. The wearable intravenous bag of claim 1 , wherein the fluidic channels of at least a subset of the second plurality of fluidic channels are substantially parallel to each other.

11. The wearable intravenous bag of claim 1 , wherein at least a subset of the second plurality of fluidic channels remains substantially parallel to each other after the intravenous bag is bent around the adjacent fluidic channels of the second plurality of fluidic channels.

12. The wearable intravenous bag of claim 1 further comprising:

a set of one or more tubes that carries the fluid from the first plurality of fluidic channels to the second plurality of fluidic channels; and

a set of one or more connectors connecting the shoulder section and the arm section;

wherein each tube in the set of tubes passes through a connector in the set of one or more connectors.

13. The wearable intravenous bag of claim 12 , wherein the shoulder section, the arm section, and the set of one or more connectors form a unitary body.

14. The wearable intravenous bag of claim 1 further comprising a pair of slits on the arm section, the pair of slits configured to hold a strap to hold the arm section against the arm of the person.

15. The wearable intravenous bag of claim 1 further comprising one or more pairs of slits, each pair of slits comprising a slit located on the shoulder section and a slit located on the arm section, each pair of slits configured to hold a strap to connect the shoulder section to the arm section.

16. The wearable intravenous bag of claim 1 further comprising a fluid transfer pipe that carries the fluid from the second plurality of fluidic channels to a fluid delivery device.

17. The wearable intravenous bag of claim 1 further comprising an injection port configured to receive a quantity of fluid other than the fluid inside the intravenous bag through one of a Y-set connector, a T-set connector, and a V-set connector.

18. The wearable intravenous bag of claim 1 , wherein the wearable intravenous bag further comprises a connection configured to fluidically connect the wearable intravenous bag to another intravenous bag that is worn by the person.

19. The wearable intravenous bag of claim 1 , wherein the fluid is one or more of a medication, a saline solution, a blood product, and nutrition.

20. The wearable intravenous bag of claim 1 further comprising a tag configured to store parameters comprising an identification of a patient, an identification of contents of the fluid in the wearable intravenous bag, and a fluid delivery schedule.

21. The wearable intravenous bag of claim 20 , wherein the tag is further configured to store titration information for the fluid in the wearable intravenous bag based on at least one vital sign of the patient.

22. The wearable intravenous bag of claim 20 , wherein the tag is one of (i) a near field communication (NFC) tag, (ii) a radio frequency identification (RFID) tag, and (iii) an optical bar code comprising one of a one-dimensional bar code and a Quick Response code (QR code).

23. The wearable intravenous bag of claim 20 , wherein the tag is one of a writable near field communication (NFC) tag and a writable radio frequency identification (RFID) tag, wherein the tag is further configured to store parameters regarding at least one of a time that the intravenous bag was used, a location where the intravenous bag was used, and a set of fluid delivery parameters.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2023
From: HATAMIAN, MEHDI; GHALEBI, MEHRTASH; ORDOUBADIAN, VAHID; MAKSOUD, CHARBEL
To: MEDICCENE INC.
Reel/Frame 065740/0312 →
Continuity (4)
Continuation In Part 17866749 · Jul 18, 2022
Continuation In Part 17557889 · Dec 21, 2021
Provisional Application 63128738 · Dec 21, 2020
Related Publication 20230329972A1 · Oct 19, 2023
References Cited (15)
US 4266298A · Graziano · 1981 [cited by examiner]
US 5492533A · Kriesel · 1996 [cited by applicant]
US 5505708A · Atkinson · 1996 [cited by applicant]
US 6074366A · Rodgers et al. · 2000 [cited by applicant]
US 6969031B2 · Ugent et al. · 2005 [cited by applicant]
US 8485727B2 · Trouilly · 2013 [cited by applicant]
US 11389376B2 · Hatamian et al. · 2022 [cited by applicant]
US 20020103451A1 · Ekey · 2002 [cited by examiner]
US 20070073368A1 · Cazzini · 2007 [cited by examiner]
US 20090095783A1 · Price · 2009 [cited by applicant]
US 20120132784A1 · Dukes et al. · 2012 [cited by applicant]
US 20150320929A1 · Simonds · 2015 [cited by applicant]
US 20200324042A1 · King et al. · 2020 [cited by applicant]
US 20230329972A1 · Hatamian et al. · 2023 [cited by applicant]
Portions of prosecution history of U.S. Appl. No. 17/557,889, filed Jun. 29, 2022, Hatamian, Mehdi. [cited by applicant]